drugset / Trial / NCT01722409
A Better Choice for Patients Undergoing Endovascular Coil Embolization
RandomizedParallel-groupDouble-blindTreatment
Summary
The investigators designed a double-blind, randomized placebo-controlled study to determine the effects of dexmedetomidine on the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.
Timeline
- Start
- 2012-12
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | — |
| Background | Sevoflurane | Other / unclassified | — | — |